Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hypercalcaemia
ADR ID BADD_A02110
ADR Hierarchy
05      Endocrine disorders
05.04      Parathyroid gland disorders
05.04.01      Hyperparathyroid disorders
05.04.01.002      Hypercalcaemia
14      Metabolism and nutrition disorders
14.04      Bone, calcium, magnesium and phosphorus metabolism disorders
14.04.01      Calcium metabolism disorders
14.04.01.003      Hypercalcaemia
Description Abnormally high level of calcium in the blood. [MeSH]
MedDRA Code 10020583
MeSH ID D006934
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Calcium repletion serum | Hypercalcaemia | Hypercalcemia | Hypercalcaemia aggravated | Hypercalcemia aggravated | Hypercalcemias | Milk-Alkali Syndrome | Milk Alkali Syndrome | Syndrome, Milk-Alkali
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01119Ibrutinib0.003730%
BADD_D01124Icodextrin--
BADD_D01130Idelalisib0.001598%
BADD_D01136Imatinib--
BADD_D01137Imatinib mesylate--
BADD_D01149Indapamide--
BADD_D01167Interferon alfa-2b--
BADD_D01204Isoniazid0.012741%
BADD_D01213Isotretinoin0.003157%
BADD_D01247Lanthanum carbonate--
BADD_D01252Leflunomide0.002066%
BADD_D01253Lenalidomide0.043424%
BADD_D01254Lenvatinib0.002131%
BADD_D01257Letrozole0.002461%
BADD_D01260Leuprolide acetate--
BADD_D01261Leuprolide monoacetate--
BADD_D01271Levocarnitine--
BADD_D01274Levodopa-4'-monophosphate--
BADD_D01285Levothyroxine0.000046%
BADD_D01303Lithium carbonate0.004088%
BADD_D01304Lithium cation--
BADD_D01305Lithium hydroxide--
BADD_D01318Lorazepam0.000134%
BADD_D01322Losartan0.000097%
BADD_D01365Medroxyprogesterone--
BADD_D01366Medroxyprogesterone acetate0.001021%
BADD_D01371Megestrol--
BADD_D01372Megestrol acetate--
BADD_D01378Memantine0.000865%
BADD_D01423Methyclothiazide--
The 4th Page    First    Pre   4 5 6 7    Next   Last    Total 7 Pages